Home›Companies›Biotech & Pharma›Synthetica Bio

Synthetica Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 29, 2023·Suggest an edit

About Synthetica Bio

Synthetica Bio is a private company based in Anaheim, California, incorporated in 2023 in Delaware. It has reported $4,250,000 raised in one offering on Form D since June 2023. Its chief executive is Simon Arkell.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 30, 2023Jun 16, 2023amended Aug 29, 2023$4,250,000fully sold16$265KOptionsRule 506(b)Form D/A ↗3 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Synthetica Bio's Form D filed Aug 29, 2023.

SA
Simon Arkell
President & CEO, director
On every Form D that Synthetica Bio has filed: 4 filings, from Jun 16, 2023 to Aug 29, 2023.
AD
Alexander Dickinson
Executive officer and director
On every Form D that Synthetica Bio has filed: 4 filings, from Jun 16, 2023 to Aug 29, 2023.

Sources

  1. SECSynthetica Bio, Inc. Form D/A, filed Aug 2, 2023
  2. SECSynthetica Bio, Inc. Form D/A, filed Jul 5, 2023
  3. SECSynthetica Bio, Inc. Form D, filed Jun 16, 2023
  4. SECSynthetica Bio, Inc. filing history